Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Mbd2em1flox/Cya
Common Name:
Mbd2-flox
Product ID:
S-CKO-03665
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mbd2-flox
Strain ID
CKOCMP-17191-Mbd2-B6N-VA
Gene Name
Mbd2
Product ID
S-CKO-03665
Gene Alias
MBD2a
Background
C57BL/6NCya
NCBI ID
17191
Modification
Conditional knockout
Chromosome
18
Phenotype
MGI:1333813
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Mbd2em1flox/Cya mice (Catalog S-CKO-03665) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000074058
NCBI RefSeq
NM_010773
Target Region
Exon 2
Size of Effective Region
~0.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Mbd2, or methyl-CpG-binding domain 2, is a “reader” protein that interprets DNA methylome-encoded information. It is associated with transcriptional regulation, chromatin structure modulation, and is involved in multiple biological processes such as cell differentiation, development, and disease [4]. It can bind to methylated CpG DNA, which is crucial for its functions in various pathways.

In mice, depletion of Mbd2 in macrophages protected against bleomycin-induced pulmonary fibrosis. Mbd2 deficiency attenuated TGF-β1 production and reduced M2 macrophage accumulation in the lung. Mechanistically, Mbd2 bound to the Ship promoter, repressed Ship expression, and enhanced PI3K/Akt signaling to promote the macrophage M2 program [1].

In tumor-related studies, knockdown of MBD2 in LUAD cells (A549 and H1975 cell lines) and B16F10 cells significantly attenuated cell migration, invasion, and epithelial-mesenchymal transition (EMT). MBD2 bound to the methylated CpG DNA within the DDB2 promoter, repressing DDB2 expression to promote tumor metastasis [2].

In cholangiocarcinoma (CCA), MBD2 was upregulated, promoting cell proliferation, migration, and chemoresistance. It interacted with WDR5, bound to the promoter of ABCB1, promoted H3K4 trimethylation through KMT2A, and activated ABCB1 expression [3].

In Th17-dominant asthma, MBD2 expression was increased, and it regulated Th17 cell differentiation by negatively regulating MINK1 [5].

In breast cancer, genetic knockout of Mbd2 in MMTV-PyMT transgenic mice impeded primary tumor growth and lung metastasis, and abrogated the expression of key determinants in epithelial-to-mesenchymal transition and impaired the activation of the PI3K/AKT pathway [6].

In septic acute kidney injury (AKI), inhibition of MBD2 by siRNA or knockout improved the survival rate, attenuated AKI, renal cell apoptosis, and inflammatory factor production. MBD2 directly bound to the promoter region CpG islands of PKCη, and activated PKCη/p38MAPK and the ERK1/2 axis [7].

In conclusion, Mbd2 plays diverse and significant roles in multiple biological processes and disease conditions. Through gene knockout studies in mouse models, its functions in pulmonary fibrosis, tumor metastasis, cholangiocarcinoma progression, Th17-dominant asthma, breast cancer, and septic AKI have been revealed. These findings provide potential therapeutic targets for these diseases by targeting Mbd2 [1,2,3,5,6,7].

References:
1. Wang, Yi, Zhang, Lei, Wu, Guo-Rao, Xiong, Weining, Wang, Cong-Yi. 2021. MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program. In Science advances, 7, . doi:10.1126/sciadv.abb6075. https://pubmed.ncbi.nlm.nih.gov/33277324/
2. Zhang, Lei, Wang, Siyuan, Wu, Guo-Rao, Yong, Tuying, Wang, Cong-Yi. 2023. MBD2 facilitates tumor metastasis by mitigating DDB2 expression. In Cell death & disease, 14, 303. doi:10.1038/s41419-023-05804-1. https://pubmed.ncbi.nlm.nih.gov/37142578/
3. Wang, Da, Chen, Junsheng, Wu, Guanhua, He, Ruizhi, Chen, Yongjun. 2024. MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5. In Journal of experimental & clinical cancer research : CR, 43, 272. doi:10.1186/s13046-024-03188-4. https://pubmed.ncbi.nlm.nih.gov/39350229/
4. Menafra, Roberta, Stunnenberg, Hendrik G. 2014. MBD2 and MBD3: elusive functions and mechanisms. In Frontiers in genetics, 5, 428. doi:10.3389/fgene.2014.00428. https://pubmed.ncbi.nlm.nih.gov/25538734/
5. Chen, Zhifeng, Shang, Yulin, Yuan, Yu, Liu, Shaokun, Xiang, Xudong. 2022. MBD2 mediates Th17 cell differentiation by regulating MINK1 in Th17-dominant asthma. In Frontiers in genetics, 13, 959059. doi:10.3389/fgene.2022.959059. https://pubmed.ncbi.nlm.nih.gov/36303542/
6. Mahmood, Niaz, Arakelian, Ani, Szyf, Moshe, Rabbani, Shafaat A. 2024. Methyl-CpG binding domain protein 2 (Mbd2) drives breast cancer progression through the modulation of epithelial-to-mesenchymal transition. In Experimental & molecular medicine, 56, 959-974. doi:10.1038/s12276-024-01205-2. https://pubmed.ncbi.nlm.nih.gov/38556549/
7. Xie, Yuxin, Liu, Bohao, Pan, Jian, Dong, Zheng, Zhang, Dongshan. 2020. MBD2 Mediates Septic AKI through Activation of PKCη/p38MAPK and the ERK1/2 Axis. In Molecular therapy. Nucleic acids, 23, 76-88. doi:10.1016/j.omtn.2020.09.028. https://pubmed.ncbi.nlm.nih.gov/33335794/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest